Loading...
Please wait, while we are loading the content...
Similar Documents
Evaluation of risk for late language emergence after in utero antiretroviral drug exposure in HIV-exposed uninfected infants.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Rice, Mabel L. Zeldow, Bret Siberry, George K. Purswani, Murli Malee, Kathleen M. Hoffman, Howard J. Frederick, Toni Buchanan, Ashley L. Sirois, Patricia A. Allison, Susannah Williams, Paige L. |
| Copyright Year | 2013 |
| Abstract | BACKGROUND Combination antiretroviral (cARV) regimens are recommended for pregnant women with HIV to prevent perinatal HIV transmission. Safety is a concern for infants who were HIV-exposed but uninfected, particularly for neurodevelopmental problems, such as language delays. METHODS We studied late language emergence (LLE) in HIV-exposed but uninfected children enrolled in a US-based prospective cohort study. LLE was defined as a caregiver-reported score ≤10th percentile in any of 4 domains of the MacArthur-Bates Communicative Development Inventory for 1-year olds and as ≥1 standard deviation below age-specific norms for the Ages and Stages Questionnaire for 2-year olds. Logistic regression models were used to evaluate associations of in utero cARV exposure with LLE, adjusting for infant, maternal and environmental characteristics. RESULTS 1129 language assessments were conducted among 792 1- and 2-year-old children (50% male, 62% black and 37% Hispanic). Overall, 86% had in utero exposure to cARV and 83% to protease inhibitors. LLE was identified in 26% of 1-year olds and 23% of 2-year olds, with higher rates among boys. In adjusted models, LLE was not associated with maternal cARV or ARV drug classes in either age group. Among cARV-exposed 1-year olds, increased odds of LLE was observed for those exposed to atazanavir (adjusted odds ratio = 1.83, 95% confidence interval: 1.10-3.04), particularly after the first trimester (adjusted odds ratio = 3.56, P = 0.001), compared with atazanavir-unexposed infants. No associations of individual ARV drugs with LLE were observed among 2-year olds. CONCLUSIONS In utero cARV exposure showed little association with LLE, except for a higher risk of language delay observed in 1-year-old infants with atazanavir exposure. |
| Starting Page | 75 |
| Ending Page | 75 |
| Page Count | 1 |
| File Format | PDF HTM / HTML |
| DOI | 10.1097/INF.0b013e31829b80ee |
| PubMed reference number | 24067563 |
| Journal | Medline |
| Volume Number | 32 |
| Issue Number | 10 |
| Alternate Webpage(s) | http://cldp.ku.edu/sites/cldp.ku.edu/files/docs/Rice,%20M.%20et%20al,%202013%20Ahead%20of%20Print.pdf |
| Alternate Webpage(s) | http://www2.ku.edu/~cldp/MabelRice/articles/Rice,%20M.%20et%20al,%202013%20Ahead%20of%20Print.pdf |
| Alternate Webpage(s) | https://kuscholarworks.ku.edu/bitstream/handle/1808/24668/Rice_2013.pdf?isAllowed=y&sequence=1 |
| Alternate Webpage(s) | http://www.clp.ku.edu/MabelRice/articles/Rice,%20M.%20et%20al,%202013%20Ahead%20of%20Print.pdf |
| Alternate Webpage(s) | http://www.natap.org/2013/HIV/Evaluation_of_Risk_for_Late_Language_Emergence.98328.pdf |
| Journal | The Pediatric infectious disease journal |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |
